Holy Name is one of 70 sites nationwide involved in the Phase 2 trial, which will test a medication that would be used to treat the flu, much like Tamiflu or Relenza, said Dr. Thomas Birch, medical director of the Institute for Clinical Research at Holy Name.
"It's a horrific season for the flu," said Jane Ellis, vice president at Holy Name Medical Center in Teaneck. "We're full to capacity — we're seeing patients with respiratory issues as well as those that have other medical conditions made worse by the flu."
Influenza is rampant across the nation, and New Jersey is smack in the middle of what local physicians are calling an epidemic. "It's here. Big time," said Dr. Thomas Birch, president of the medical staff at Holy Name Medical Center. "When the virus comes into a community with susceptible individuals, it will literally spread like those wildfires in California that burn everything in their path."
Thomas Birch, MD, is an infectious disease specialist and Medical Director of the Institute for Clinical Research at Holy Name Medical Center. Dr. Birch is heading up Holy Name's participation in a new Phase 2 trial overseen by the US. Department of Defense to test a medication to treat flu symptoms.